These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 22619554

  • 1. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.
    Hanagata N.
    Int J Nanomedicine; 2012; 7():2181-95. PubMed ID: 22619554
    [Abstract] [Full Text] [Related]

  • 2. Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.
    Meng W, Yamazaki T, Nishida Y, Hanagata N.
    BMC Biotechnol; 2011 Sep 26; 11():88. PubMed ID: 21943407
    [Abstract] [Full Text] [Related]

  • 3. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
    Lai CY, Yu GY, Luo Y, Xiang R, Chuang TH.
    Front Immunol; 2019 Sep 26; 10():179. PubMed ID: 30800129
    [Abstract] [Full Text] [Related]

  • 4. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
    Yu C, An M, Li M, Liu H.
    Mol Pharm; 2017 Aug 07; 14(8):2815-2823. PubMed ID: 28686452
    [Abstract] [Full Text] [Related]

  • 5. CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies.
    Hanagata N.
    Int J Nanomedicine; 2017 Aug 07; 12():515-531. PubMed ID: 28144136
    [Abstract] [Full Text] [Related]

  • 6. Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials.
    Lee SW, Song MK, Baek KH, Park Y, Kim JK, Lee CH, Cheong HK, Cheong C, Sung YC.
    J Immunol; 2000 Oct 01; 165(7):3631-9. PubMed ID: 11034366
    [Abstract] [Full Text] [Related]

  • 7. The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs.
    Bjersing JL, Eriksson K, Tarkowski A, Collins LV.
    Inflammation; 2004 Feb 01; 28(1):39-51. PubMed ID: 15072229
    [Abstract] [Full Text] [Related]

  • 8. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
    Gekeler V, Gimmnich P, Hofmann HP, Grebe C, Römmele M, Leja A, Baudler M, Benimetskaya L, Gonser B, Pieles U, Maier T, Wagner T, Sanders K, Beck JF, Hanauer G, Stein CA.
    Oligonucleotides; 2006 Feb 01; 16(1):83-93. PubMed ID: 16584297
    [Abstract] [Full Text] [Related]

  • 9. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
    Takahashi H, Misato K, Aoshi T, Yamamoto Y, Kubota Y, Wu X, Kuroda E, Ishii KJ, Yamamoto H, Yoshioka Y.
    Front Immunol; 2018 Feb 01; 9():783. PubMed ID: 29720976
    [Abstract] [Full Text] [Related]

  • 10. Construction of Monomeric and Dimeric G-Quadruplex-Structured CpG Oligodeoxynucleotides for Enhanced Uptake and Activation in TLR9-Positive Macrophages.
    Liao W, Tan M, Kusamori K, Takakura Y, Nishikawa M.
    Nucleic Acid Ther; 2020 Oct 01; 30(5):299-311. PubMed ID: 32559406
    [Abstract] [Full Text] [Related]

  • 11. Conjugation of lipid and CpG-containing oligonucleotide yields an efficient method for liposome incorporation.
    Andrews CD, Provoda CJ, Ott G, Lee KD.
    Bioconjug Chem; 2011 Jul 20; 22(7):1279-86. PubMed ID: 21612239
    [Abstract] [Full Text] [Related]

  • 12. Nanodelivery systems for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides.
    Zhang H, Gao XD.
    Mater Sci Eng C Mater Biol Appl; 2017 Jan 01; 70(Pt 2):935-946. PubMed ID: 27772724
    [Abstract] [Full Text] [Related]

  • 13. Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9.
    Fehér K.
    Curr Protein Pept Sci; 2019 Jan 01; 20(11):1060-1068. PubMed ID: 31470785
    [Abstract] [Full Text] [Related]

  • 14. Innovative strategies for co-delivering antigens and CpG oligonucleotides.
    Krishnamachari Y, Salem AK.
    Adv Drug Deliv Rev; 2009 Mar 28; 61(3):205-17. PubMed ID: 19272328
    [Abstract] [Full Text] [Related]

  • 15. Novel immunostimulatory phosphodiester oligodeoxynucleotides with CpT sequences instead of CpG motifs.
    Kim D, Jung J, Lee Y, Kwon HJ.
    Mol Immunol; 2011 Jul 28; 48(12-13):1494-504. PubMed ID: 21529949
    [Abstract] [Full Text] [Related]

  • 16. Effects of G-Quadruplex Ligands on the Topology, Stability, and Immunostimulatory Properties of G-Quadruplex-Based CpG Oligodeoxynucleotides.
    Tu ATT, Hoshi K, Ma Y, Oyama T, Suzuki S, Tsukakoshi K, Nagasawa K, Ikebukuro K, Yamazaki T.
    ACS Chem Biol; 2022 Jul 15; 17(7):1703-1713. PubMed ID: 35765965
    [Abstract] [Full Text] [Related]

  • 17. Enhanced immunostimulatory activity of oligodeoxynucleotides by Y-shape formation.
    Nishikawa M, Matono M, Rattanakiat S, Matsuoka N, Takakura Y.
    Immunology; 2008 Jun 15; 124(2):247-55. PubMed ID: 18217956
    [Abstract] [Full Text] [Related]

  • 18. Leishmanial CpG DNA nanovesicles: A propitious prophylactic approach against visceral leishmaniasis.
    Tiwari RK, Chandrakar P, Gupta CL, Sayyed U, Shekh R, Bajpai P.
    Int Immunopharmacol; 2021 Jan 15; 90():107181. PubMed ID: 33249044
    [Abstract] [Full Text] [Related]

  • 19. G-Quadruplex Structure Improves the Immunostimulatory Effects of CpG Oligonucleotides.
    Hoshi K, Yamazaki T, Sugiyama Y, Tsukakoshi K, Tsugawa W, Sode K, Ikebukuro K.
    Nucleic Acid Ther; 2019 Aug 15; 29(4):224-229. PubMed ID: 30835633
    [Abstract] [Full Text] [Related]

  • 20. Structural and immunostimulatory properties of Y-shaped DNA consisting of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Matsuoka N, Nishikawa M, Mohri K, Rattanakiat S, Takakura Y.
    J Control Release; 2010 Dec 20; 148(3):311-6. PubMed ID: 20887761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.